These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 27343466)

  • 1. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy.
    Zhao X; Yang K; Zhao R; Ji T; Wang X; Yang X; Zhang Y; Cheng K; Liu S; Hao J; Ren H; Leong KW; Nie G
    Biomaterials; 2016 Sep; 102():187-97. PubMed ID: 27343466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression.
    Lu J; Liu X; Liao YP; Salazar F; Sun B; Jiang W; Chang CH; Jiang J; Wang X; Wu AM; Meng H; Nel AE
    Nat Commun; 2017 Nov; 8(1):1811. PubMed ID: 29180759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.
    Fang H; Ang B; Xu X; Huang X; Wu Y; Sun Y; Wang W; Li N; Cao X; Wan T
    Cell Mol Immunol; 2014 Mar; 11(2):150-9. PubMed ID: 24362470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
    He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation.
    Luo S; Yang Y; Chen L; Kannan PR; Yang W; Zhang Y; Zhao R; Liu X; Li Y; Kong X
    Acta Biomater; 2024 Jun; 181():402-414. PubMed ID: 38734282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergizing autophagic cell death and oxaliplatin-induced immunogenic death by a self-delivery micelle for enhanced tumor immunotherapy.
    Deng T; Chen D; Chen F; Xu C; Zhang Q; Li M; Wang Y; He Z; Li M; He Q
    Acta Biomater; 2024 Dec; 190():548-559. PubMed ID: 39426655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
    Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
    J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles.
    Qian C; Wang Y; Chen Y; Zeng L; Zhang Q; Shuai X; Huang K
    Biomaterials; 2013 Aug; 34(26):6175-84. PubMed ID: 23721794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death.
    Huang Y; Wei D; Wang B; Tang D; Cheng A; Xiao S; Yu Y; Huang W
    Acta Biomater; 2023 Apr; 160():198-210. PubMed ID: 36792048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
    Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
    J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-mediated immunogenic cell death for cancer immunotherapy.
    Qi H; Li Y; Geng Y; Wan X; Cai X
    Int J Pharm; 2024 May; 656():124045. PubMed ID: 38561134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy.
    Wang Y; Xie W; Humeau J; Chen G; Liu P; Pol J; Zhang Z; Kepp O; Kroemer G
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual-pathway pyroptosis inducer based on Au-Cu
    Yan X; Chen C; Ren Y; Su T; Chen H; Yu D; Huang Y; Chao M; Wu G; Jiang G; Gao F
    Acta Biomater; 2024 Oct; 188():329-343. PubMed ID: 39278301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cobalt(III) prodrug-based nanomedicine for inducing immunogenic cell death and enhancing chemo-immunotherapy.
    Shang K; Montesdeoca N; Zhang H; Efanova E; Liang G; Ochs J; Karges J; Song H; Zhang L
    J Control Release; 2024 Sep; 373():493-506. PubMed ID: 39033985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer.
    Si Y; Yue J; Liu Z; Li M; Du F; Wang X; Dai Z; Hu N; Ju J; Gao S; Wang X; Yuan P
    Int J Nanomedicine; 2021; 16():1913-1926. PubMed ID: 33707946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducing Optimal Antitumor Immune Response through Coadministering iRGD with Pirarubicin Loaded Nanostructured Lipid Carriers for Breast Cancer Therapy.
    Deng C; Jia M; Wei G; Tan T; Fu Y; Gao H; Sun X; Zhang Q; Gong T; Zhang Z
    Mol Pharm; 2017 Jan; 14(1):296-309. PubMed ID: 27936775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach.
    Lu Y; Wang Y; Miao L; Haynes M; Xiang G; Huang L
    Cancer Lett; 2016 Aug; 379(1):32-8. PubMed ID: 27235608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation.
    Li SY; Liu Y; Xu CF; Shen S; Sun R; Du XJ; Xia JX; Zhu YH; Wang J
    J Control Release; 2016 Jun; 231():17-28. PubMed ID: 26829099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors.
    May JP; Ernsting MJ; Undzys E; Li SD
    Mol Pharm; 2013 Dec; 10(12):4499-508. PubMed ID: 24152292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.